Pharmaceutical Sector

.

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd BSE 3.72 % went up to 6.2 per cent in exchange on Monday, after the pharma major said that its new medication revelation program in hostile to infective exploration and has gotten a real help after two of its medications, WCK 771 and WCK 2349, got the Qualified Infectious Disease Product (QIDP) status from the US FDA.

Ackman and Valeant call for special meeting of Allergan shareholders

Ackman and Valeant call for special meeting of Allergan shareholders

William Ackman, who is an activist investor and Valeant Pharmaceuticals International have called for a special meeting with the shareholders of Allergan Inc over their takeover bid for the company.

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen the major drugstore chain of late faced pressure from the shareholders to shift overseas so as to lessen its tax bill like many other drug companies have done recently. Walgreen was earlier looking forward to become a part of a possible agreement with Alliance Boots GmbH the European drugstore chain.

Novartis Expects major part of Revenue from New Products

Novartis Expects major part of Revenue from New Products

Novartis International AG, a Swiss multinational pharmaceutical company based in Basel, was ranked number one in sales among the world-wide industry in 2013.

On Thursday, Bombay Stock Exchange reported a 2% rise in quarterly sales of the company along with an expected future increase in the revenue of the company with the introduction of their new products.

Shire Gets Ready To Accept New Offer From AbbVie

Shire Gets Ready To Accept New Offer From AbbVie

Shire, the Dublin based drug manufacturer says that it is ready to urge a fresh £31bn takeover offer that came from AbbVie. It is entering into discussions with the firm after it received its fifth bid from the Chicago-based firm.

US approval for Qiagen

US approval for Qiagen

U. S. wellbeing controllers on Friday sanction Qiagen NV's gene-trying pack to recognize those colorectal malignancy patients destined to profit from Amgen Inc's pill, Vectibix, Qiagen said.

Still More to See in Pfizer's bid for AstraZeneca

Still More to See in Pfizer's bid for AstraZeneca

On Saturday, the story of takeover bid of the 63bn AstraZeneca by American pharmaceutical giant Pfizer took a new twist. It appeared that ministers have started discussions in Brussels regarding strengthening UK's capacity to pressurize the American firm to respect its commitment on issues related to jobs and research.

Valeant Gains Following Takeover Bid But Slips Again

Valeant Gains Following Takeover Bid But Slips Again

Wiping out the initial advance that it made during the trading hours, the stock of Valeant Pharmaceuticals International Inc. slipped.

Experimental Hepatitis C Drug Registers 95% Success Rate

Experimental Hepatitis C Drug Registers 95% Success Rate

German Researchers have claimed that an experimental Hepatitis Drug has registered 95 percent success rate even in cases of failure of earlier treatment. The drug could be termed as blockbuster but the major issue is the high cost of treatment.

EU backs endocyte ovarian cancer drug

EU backs endocyte ovarian cancer drug

The drug giant, Endocyte Inc. has finally got the approval which was crucial to them from the advisors of EU for their endorsement of ovarian cancer drug Vynfinit.

Latest News

Fourth Quarter Loss Posted by Walgreen
Steve Wynn, Casino Magnate Says Gambling Industry is not about Slot Machines
News Corp. to Buy Move Inc. for $950 million
Will PayPal soon Look for Mergers with Mobile Payment Services to fight Competit
Ford Shares Drop With Profit Concerns
Dominion LNG Export Project Gets Green Signal from FERC
Second Quarter Shows Fastest Growth of U.S Economy
Stronger Safeguarding Rules for Service Members Against Predatory Lenders
Yahoo Urged to Buy Rival AOL Inc.
Slowing Down of Inflation May Make it Difficult for BOJ to Achieve its Target
B.K. Modi’s CIO Plans to Start Pre-IPO Fund
American Soda makers Promise to Trim Twenty Percent Calories by 2025
Syndicate content